Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir”

220 trials

Showing 20 of 220 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Large-scale testing (Phase 3)WithdrawnNCT00476983
What this trial is testing

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Who this might be right for
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
The HIV Netherlands Australia Thailand Research Collaboration
Large-scale testing (Phase 3)Study completedNCT00272779
What this trial is testing

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Who this might be right for
HIV Infections
Bristol-Myers Squibb 1,057
Testing effectiveness (Phase 2)Ended earlyNCT00144105
What this trial is testing

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Who this might be right for
HIV Infections
Boehringer Ingelheim 562
Post-approval studies (Phase 4)Ended earlyNCT00765154
What this trial is testing

NNRTI/PI Toxicity Switch to Darunavir Study

Who this might be right for
HIV
St Stephens Aids Trust 12
Not applicableStudy completedNCT01074931
What this trial is testing

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Who this might be right for
HIV-1 Infections
Abbott 98
Large-scale testing (Phase 3)Study completedNCT00035932
What this trial is testing

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Who this might be right for
HIV Infections
Bristol-Myers Squibb 571
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT01227590
What this trial is testing

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Who this might be right for
Drug InteractionsHuman Immunodeficiency Virus
University of California, San Francisco 18
Early research (Phase 1)Study completedNCT01571414
What this trial is testing

Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Testing effectiveness (Phase 2)Study completedNCT00116636
What this trial is testing

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Who this might be right for
HIV Infections
Therapeutic Concepts 40
Early research (Phase 1)Study completedNCT00920088
What this trial is testing

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT04276688
What this trial is testing

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Who this might be right for
Novel Coronavirus Infection
The University of Hong Kong 127
Post-approval studies (Phase 4)Study completedNCT00160849
What this trial is testing

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Who this might be right for
HIV Infections
Universidade Federal do Rio de Janeiro 60
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Large-scale testing (Phase 3)Study completedNCT01002898
What this trial is testing

Ritonavir-boosted Lopinavir Monotherapy

Who this might be right for
HIV
Bamrasnaradura Infectious Diseases Institute 40
Not applicableStudy completedNCT01328158
What this trial is testing

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 236
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation